CellaVision AB (publ)
CLVSFOTCHealthcare● Active
$13.49
+$0.00(+0.00%)
Market Cap$321757369
P/E Ratio—
52W High$19.2796
52W Low$13.49
CellaVision AB (publ) (CLVSF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CLVSF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.76B | $0.72B | $0.68B | $0.64B | $0.57B |
| Cost of Revenue | $0.24B | $0.24B | $0.21B | $0.20B | $0.17B |
| Gross Profit | $0.52B | $0.49B | $0.46B | $0.44B | $0.39B |
| Gross Margin %(computed) | 68.50% | 67.35% | 68.37% | 68.56% | 69.37% |
| Operating Expenses | |||||
| R&D Expenses | $0.10B | $0.09B | $0.08B | $0.09B | $0.06B |
| G&A Expenses | $0.09B | $0.09B | $0.08B | $0.07B | $0.06B |
| Total Operating Expenses | $0.32B | $0.31B | $0.30B | $0.28B | $0.23B |
| Operating Income | $0.20B | $0.18B | $0.17B | $0.16B | $0.16B |
| Operating Margin %(computed) | 26.62% | 24.57% | 24.66% | 24.75% | 28.77% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.19B | $0.18B | $0.16B | $0.15B | $0.16B |
| Income Tax Expense | $0.04B | $0.04B | $0.03B | $0.03B | $0.03B |
| Net Income | $0.15B | $0.14B | $0.13B | $0.12B | $0.13B |
| Net Margin %(computed) | 20.17% | 19.46% | 19.24% | 18.51% | 22.16% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $6.42 | $5.90 | $5.46 | $4.96 | $5.25 |
| Wtd Avg Shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B |
| EBITDA | $0.24B | $0.22B | $0.21B | $0.19B | $0.19B |
| EBITDA Margin %(computed) | 31.19% | 30.39% | 30.60% | 29.85% | 34.23% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · SEK · B
Explore more CellaVision AB (publ) data
About CellaVision AB (publ) (CLVSF) Income Statement
CellaVision AB (publ) (CLVSF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CLVSF reported revenue of $0.76B, gross profit of $0.52B (gross margin 68.50%), and net income of $0.15B — a net profit margin of 20.17%.
Frequently asked questions
CLVSF · 4 questionsCellaVision AB (publ) (CLVSF) reported revenue of $0.76B for 2025, up 4.9% year-over-year.
CLVSF revenueCLVSF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09